These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29800290)

  • 21. Necessity of carbapenem use when prescribed per infectious diseases specialists.
    Goodlet KJ; Nailor MD
    Diagn Microbiol Infect Dis; 2017 May; 88(1):41-46. PubMed ID: 28291632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
    Metan G; Kaynar L; Yozgat N; Elmali F; Kürkçüoglu CA; Alp E; Çetin M
    Infez Med; 2017 Mar; 25(1):33-37. PubMed ID: 28353453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia.
    Tamma PD; Han JH; Rock C; Harris AD; Lautenbach E; Hsu AJ; Avdic E; Cosgrove SE;
    Clin Infect Dis; 2015 May; 60(9):1319-25. PubMed ID: 25586681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbapenem use in French hospitals: A nationwide survey at the patient level.
    Gauzit R; Pean Y; Alfandari S; Bru JP; Bedos JP; Rabaud C; Robert J; ; ;
    Int J Antimicrob Agents; 2015 Dec; 46(6):707-12. PubMed ID: 26508585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study.
    Réa-Neto A; Niederman M; Lobo SM; Schroeder E; Lee M; Kaniga K; Ketter N; Prokocimer P; Friedland I
    Curr Med Res Opin; 2008 Jul; 24(7):2113-26. PubMed ID: 18549664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From intermittent antibiotic point prevalence surveys to quality improvement: experience in Scottish hospitals.
    Malcolm W; Nathwani D; Davey P; Cromwell T; Patton A; Reilly J; Cairns S; Bennie M
    Antimicrob Resist Infect Control; 2013 Jan; 2(1):3. PubMed ID: 23320479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.
    Harris PNA; Tambyah PA; Lye DC; Mo Y; Lee TH; Yilmaz M; Alenazi TH; Arabi Y; Falcone M; Bassetti M; Righi E; Rogers BA; Kanj S; Bhally H; Iredell J; Mendelson M; Boyles TH; Looke D; Miyakis S; Walls G; Al Khamis M; Zikri A; Crowe A; Ingram P; Daneman N; Griffin P; Athan E; Lorenc P; Baker P; Roberts L; Beatson SA; Peleg AY; Harris-Brown T; Paterson DL;
    JAMA; 2018 Sep; 320(10):984-994. PubMed ID: 30208454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between the usage of carbapenem antibiotics and the incidence of imipenem-resistant Pseudomonas aeruginosa.
    Fujimura S; Nakano Y; Sato T; Shirahata K; Watanabe A
    J Infect Chemother; 2007 Jun; 13(3):147-50. PubMed ID: 17593500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Widespread increase of empirical carbapenem use in acute care hospitals in Catalonia, Spain.
    Grau S; Fondevilla E; Echeverría-Esnal D; Alcorta A; Limon E; Gudiol F;
    Enferm Infecc Microbiol Clin (Engl Ed); 2019 Jan; 37(1):36-40. PubMed ID: 29703463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time series analysis of the impact of an intervention in Tayside, Scotland to reduce primary care broad-spectrum antimicrobial use.
    Hernandez-Santiago V; Marwick CA; Patton A; Davey PG; Donnan PT; Guthrie B
    J Antimicrob Chemother; 2015 Aug; 70(8):2397-404. PubMed ID: 25953807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic prescription in intensive care units in Latin America.
    Curcio DJ;
    Rev Argent Microbiol; 2011; 43(3):203-11. PubMed ID: 22430995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Point prevalence data on antimicrobial usage in Italian acute-care hospitals: Evaluation and comparison of results from two national surveys (2011-2016).
    Vicentini C; Quattrocolo F; D'Ambrosio A; Corcione S; Ricchizzi E; Moro ML; De Rosa FG; Zotti CM
    Infect Control Hosp Epidemiol; 2020 May; 41(5):579-584. PubMed ID: 32043437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a Carbapenem-Saving Strategy Using Empirical Combination Regimen of Piperacillin-Tazobactam and Amikacin in Hemato-Oncology Patients.
    Ko JH; Kim SH; Kang CI; Cho SY; Lee NY; Chung DR; Peck KR; Song JH
    J Korean Med Sci; 2019 Jan; 34(2):e17. PubMed ID: 30636947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic review: can one prescribe carbapenems to patients with IgE-mediated allergy to penicillins or cephalosporins?
    Kula B; Djordjevic G; Robinson JL
    Clin Infect Dis; 2014 Oct; 59(8):1113-22. PubMed ID: 25048853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic consumption versus the prevalence of carbapenem-resistant Gram-negative bacteria at a tertiary hospital in China from 2011 to 2017.
    Zhang D; Hu S; Sun J; Zhang L; Dong H; Feng W; Lei J; Dong Y
    J Infect Public Health; 2019; 12(2):195-199. PubMed ID: 30385238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical impact of a prospective audit with intervention and feedback without carbapenem restriction in patients receiving carbapenem injection.
    Fujibayashi A; Niwa T; Takeichi S; Suzuki K; Ohta H; Niwa A; Tsuchiya M; Yamamoto M; Hatakeyama D; Suzuki A; Baba H; Murakami N; Itoh Y
    Int J Clin Pract; 2019 Jan; 73(1):e13262. PubMed ID: 30259617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial stewardship for carbapenem use at a Japanese tertiary care center: An interrupted time series analysis on the impact of infectious disease consultation, prospective audit, and feedback.
    Tagashira Y; Horiuchi M; Tokuda Y; Heist BS; Higuchi M; Honda H
    Am J Infect Control; 2016 Jun; 44(6):708-10. PubMed ID: 26831278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. European Antibiotic Awareness Day provides platform for campaigns on prudent use of antibiotics for the fourth time.
    Eurosurveillance editorial team
    Euro Surveill; 2011 Nov; 16(46):. PubMed ID: 22115048
    [No Abstract]   [Full Text] [Related]  

  • 39. Sparing carbapenem usage.
    Wilson APR
    J Antimicrob Chemother; 2017 Sep; 72(9):2410-2417. PubMed ID: 28637307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Point prevalence survey of antimicrobial utilization in the cardiac and pediatric critical care unit.
    Blinova E; Lau E; Bitnun A; Cox P; Schwartz S; Atenafu E; Yau Y; Streitenberger L; Parshuram CS; Marshall J; Seto W
    Pediatr Crit Care Med; 2013 Jul; 14(6):e280-8. PubMed ID: 23823209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.